Cynthia L Gay MD MPH
Associate Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine
Join to view full profile
101 Manning DrChapel Hill, NC 27514
Phone+1 919-966-4996
Fax+1 919-843-5515
Dr. Gay is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Cynthia Gay is an infectious disease specialist in Chapel Hill, NC and is affiliated with University of North Carolina Hospitals. She received her medical degree from University of North Carolina at Chapel Hill School of Medicine and has been in practice 18 years. She is experienced in hiv/aids and infectious disease. She has more than 100 publications.
Education & Training
University of North Carolina HospitalsFellowship, Infectious Disease, 2003 - 2006
Vanderbilt University Medical CenterResidency, Internal Medicine, 1999 - 2002
University of North Carolina at Chapel Hill School of MedicineClass of 1999
University of North Carolina School of Public HealthM.P.H., Maternal and Child Health, 1998- University of Maryland, College ParkNo degree, Post Graduate Pre Medical Course Work, 1992 - 1993
Certifications & Licensure
NC State Medical License 2003 - 2026
TN State Medical License 2001 - 2004
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Geriatric Medicine
Awards, Honors, & Recognition
- Poster Winner � People�s Favorite, Quality Expo, �OraQuick Testing Utilization in a High Risk Patient Population� UNC School of Medicine, 2013
- Merit Distinction, Scientific Programme Committee, 6th International Conference on HIV Pathogenesis, Treatment and Prevention AIDS Society, 2011
- Clinical Infectious Diseases Award for Outstanding Review 2010
Clinical Trials
Publications & Presentations
PubMed
- Changes in Doravirine Pharmacokinetics During Pregnancy: A Longitudinal Single Dose Study.Amanda Poliseno, Lisa Rahangdale, Amanda Schauer, Craig Sykes, Cynthia Gay
The Journal of Infectious Diseases. 2026-09-26 - Single-Dose Longitudinal Pharmacokinetic Evaluation of Doravirine in Pregnant Women Living With HIV: Protocol for a Phase 1 Study.Amanda Poliseno, Lisa Rahangdale, Cynthia Gay, Emma Trawick Roberts, Angela Kashuba
JMIR Research Protocols. 2026-07-10 - 1 citationsAnalysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine.Youyi Fong, Yunda Huang, Ying Huang, Wayne Woo, Alice McGarry
Clinical Infectious Diseases. 2026-04-30
Journal Articles
- Results of a Social Network Testing Intervention for HIV in Infectious Disease ClinicsAimee Wilkin, Cynthia L Gay, AIDS and Behavior
- Results of a Social Network Testing Intervention for HIV in Infectious Disease ClinicsLeViere A, Donovan J, Wilkin A, Keller J, Parnell H, Sampson L, Gay CL, Quinlivan EB, AIDS Behav, 1/5/2018
- Virological and immunological responses to raltegravir and dolutegravir in the gut-associated lymphoid tissue of HIV-infected men and womenWeber MD, Andrews E, Prince HA, Sykes C, Rosen EP, Bay C, Shaheen NJ, Madanick RD, Dellon ES, De Paris K, Nelson JA, Gay CL, Kashuba AD, J Clin Invest, 1/1/2018
Books/Book Chapters
Abstracts/Posters
- Near full-length sequence analysis reveals no evidence of HIV-1 replication during therapyLee SK, Rogers A, Xu Y, Warren J, Goonetilleke N, Zhou S, Pond SK, Bednar M, Hauser B, Gay C, Kuruc J, Archin N, Eron J, Margolis D, Swanstrom R, 22nd International AIDS Conference, Amsterdam, Netherlands, 1/23/2018
- Altered TDF/FTC pharmacology in a transgender female cohort: Implications for PrePCottrell, ML, Prince HM, Maffuid K, Poliseno A, White N, Sykes C, Nelson JA, Peery A, Dellon E, Hightow-Weidman L, Adams JL, Gay C, Kashuba A, 22nd International AIDS Conference, Amsterdam, Netherlands, 1/23/2018
- Comparing time to viral suppression among acute and non-acute HIV in North CarolinaAdams DA, Cope A, Wheeler B, Mobley V, Barnhart J, Kuruc JD, Gay CL, Filiatreau LM, Ashby R, Samoff E, Conference on Retroviruses and Opportunistic Infections, Boston, MA, 1/4/2018
Lectures
- Discuss unknown clinical cases using my clinical experience and knowledge of the medical literatureUniversity of North Carolina, Chapel Hill, NC - 1/1/2018
- Treatment and Prophylaxis of AIDS Opportunistic InfectionsInfectious Diseases Boot Camp for incoming ID fellows - 1/1/2018
- Antibodies & HIV Prevention: Thinking Outside the Box and On TargetChapel Hill, NC - 1/21/2016
Other
- Prevention of sexually transmitted infectionsGay CL, Cohen MS
http://www.uptodate.com/contents/prevention-of-sexually-transmitted-infections
UpToDate, Wolters Kluwer Health - 2012-11-15 - HIV � A Global PerspectiveGay C, UNC Foundations for Global Health Course
Press Mentions
Virginia Set to Receive 20K Doses of Novavax VaccineJuly 24th, 2022- NewsweekJanuary 5th, 2022
- Vaccines Are Coming to NC’s Prisons. Who Should Get First Priority?December 9th, 2020
Grant Support
- The Stop StudyNational Center For Hiv, Viral Hepatitis, Stds And Tb Prevention2011–2012
- Longitudinal Assessment Of Acute HIV InfectionNational Center For Research Resources2008
- Clinical Trial: Once Daily Regimen Of Didanosine, Tenofovir And EfavirenzNational Center For Research Resources2008
- Clinical Trial: ACTG A5217 - Treatment VS NO Treatment In Newly Infected HIV-1 SNational Center For Research Resources2008
- Acute HIV Infection And Early Disease Research ProgramNational Center For Research Resources2007–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: